| Unbiased screens show CD8+ T cells of COVID-19 patients recognize shared epitopes in SARS-CoV-2 that largely reside outside the spike protein AP Ferretti, T Kula, Y Wang, DMV Nguyen, A Weinheimer, GS Dunlap, ... Immunity 53 (5), 1095-1107. e3, 2020 | 322 | 2020 |
| A pressure test to make 10 molecules in 90 days: external evaluation of methods to engineer biology A Casini, FY Chang, R Eluere, AM King, EM Young, QM Dudley, A Karim, ... Journal of the American Chemical Society 140 (12), 4302-4316, 2018 | 152 | 2018 |
| COVID-19 patients form memory CD8+ T cells that recognize a small set of shared immunodominant epitopes in SARS-CoV-2 AP Ferretti, T Kula, Y Wang, DMV Nguyen, A Weinheimer, GS Dunlap, ... MedRxiv, 2020.07. 24.20161653, 2020 | 20 | 2020 |
| Prediction of whole-cell transcriptional response with machine learning M Eslami, AE Borujeni, H Eramian, M Weston, G Zheng, J Urrutia, ... Bioinformatics 38 (2), 404-409, 2022 | 9 | 2022 |
| A toolkit for enhanced reproducibility of RNASeq analysis for synthetic biologists BJ Garcia, J Urrutia, G Zheng, D Becker, C Corbet, P Maschhoff, ... Synthetic Biology 7 (1), ysac012, 2022 | 4 | 2022 |
| Unbiased screens show CD8+ T cells of COVID-19 patients recognize shared epitopes in SARS-CoV-2, most of which are not located in the Spike protein AP Ferretti, T Kula, Y Wang, DMV Nguyen, A Weinheimer, GS Dunlap, ... Immunity, 0 | 2 | |
| COVID-19 Patients Form Memory CD8+ T Cells that Recognize a Small Set of Shared Immunodominant Epitopes in SARS-CoV-2 (preprint) AP Ferretti, T Kula, Y Wang, DMV Nguyen, A Weinheimer, GS Dunlap, ... | 1 | 2020 |
| Discovery of MAGE-A1-specific TCR-T cell therapy candidates to expand multiplex therapy of solid tumors J Tadros, N Nabilsi, M Jurewicz, A Sharma, K Jahan, N Gaspar, K Cirelli, ... | | 2023 |
| 376 Overcoming tumor heterogeneity–Clinical trial assays to prospectively assign patients customized multiplexed TCR-T cell therapy in Phase 1 R Nayar, SA Khokhar, S Jangalwe, S Padmanabhan, N Nabilsi, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| 364 Non-clinical development of T-Plex component TSC-200-A0201: a natural HPV16 E7-specific TCR-T cell therapy for the treatment of HPV16-positive solid tumors S Jangalwe, B Kiaf, DC Pollacksmith, S Kamalia, S Padmanabhan, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
| 156 Discovery of TSC-100: A natural HA-1-specific TCR to treat leukemia following hematopoietic stem cell transplant therapy R Nayar, S Jangalwe, M Jurewicz, A Boudot, A Basinski, R Prenovitz, ... Journal for ImmunoTherapy of Cancer 8 (Suppl 3), 2020 | | 2020 |
| Comprehensive Identification of Tumor-Reactive TCRs and Cognate Targets for Novel TCR T-Cell Cancer Therapies Y Wang, A Ferretti, N Nabilsi, Q Xu, A Cristofaro, A Weinheimer, K Jahan, ... MOLECULAR THERAPY 28 (4), 501-501, 2020 | | 2020 |
